The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

DNLI FINANCIAL STATEMENTS

Denali Therapeutics Inc — balance sheet, income statement and cash flow trends

DNLIDenali Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M-250 M0250 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue3.6 M $Gross Profit-104.2 M $ · -2890%Operating Income-542.7 M $ · -15058%Pre-tax Income-511.3 M $ · -14188%Net Income to Owners-511.5 M $ · -14191%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue3.6 M $—
Gross Profit-104.2 M $—
Operating Income-542.7 M $—
EBITDA-497.3 M $—
Net Income to Owners-511.5 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.2 B
  • Equity835.2 M $72%
  • Current Liabilities90.1 M $8%
  • Long-term Liabilities232.7 M $20%

Key Figures

YoY change
Total Assets1.2 B $-0.7%
Total Liabilities322.8 M $+131.9%
Total Equity835.2 M $-18.7%
Cash & ST Investments710.5 M $-21.0%
Total Debt27.5 M $-40.9%
Net Debt-174 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-250 M0250 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-434 M $Operating69 M $Investing425.4 M $Financing60.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-434 M $—
Capital Expenditures6.2 M $-66.3%
Free Cash Flow-437.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on DNLI

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.